Search Results - tomar+ghansah

3 Results Sort By:
SHIP-1 Agonists for Pancreatic Cancer Treatment
­Advantages: SHIP-1 as a new molecular target to improve anti-tumor immunity and enhance immune checkpoint immunotherapy responses SHIP-1 agonists API and K306 as therapeutics for treating pancreatic cancer Combination treatment of a SHIP-1 agonist with a checkpoint inhibitor synergistically reduces tumor burden Summary: Portfolio includes...
Published: 6/11/2024   |   Inventor(s): Tomar Ghansah
Keywords(s): Biotechnology, Cancer Treatment, Diagnostics
Category(s): Technology Classifications > Medical > Oncology, Technology Classifications > Medical > Medical Diagnostics
SHIP-1: Biomarker and Therapeutic Target to Reduce Health Disparities in African Americans with Pancreatic Cancer
­Advantages: SHIP-1 as a new molecular target to improve anti-tumor immunity and enhance immune checkpoint immunotherapy responses SHIP-1 agonists API and K306 as therapeutics for treating pancreatic cancer Combination treatment of a SHIP-1 agonist with a checkpoint inhibitor synergistically reduces tumor burden Summary: Portfolio included...
Published: 6/11/2024   |   Inventor(s): Tomar Ghansah
Keywords(s): Cancer Treatment
Category(s): Technology Classifications > Medical > Therapeutics, Technology Classifications > Medical > Oncology
SHIP-1 Regulation of Tumoricidal Myeloid Cells in Pancreatic Cancer
Advantages: Proposes a method that aids in the therapeutic intervention of Pancreatic Ductal Adenocarcinoma Administering therapeutic agents, such as apigenin, potentially improves anti-tumor responses Method of monitoring helps track the progression and regression of the disease Summary: Pancreatic Ductal Adenocarcinoma (PDAC) is one of the...
Published: 2/1/2024   |   Inventor(s): Tomar Ghansah
Keywords(s): Cancer Diagnostics, Cancer Treatment, Medical Diagnostics, Therapeutics
Category(s): Technology Classifications > Cancer